targeted

STMicroelectronics and US company Automotive Communications Systems are to jointly create communications ics for vehicle and infrastructure integration (VII) applications. The VII initiative is investigating the potential safety benefits of car to car and car to roadside high speed communications. “There is clearly enormous potential for the technology that ACS brings to solving problems facing the VII program,” said Ugo Carena general manager of ST’s automotive products group pictured. “Our capability in automotive wireless communication and location coupled with ACS’ technology ordain provide significant advantages to the government auto companies and their suppliers.”“We are excited to be working with … STMicroelectronics,” said Milt Baker ceo of ACS. “The synergy of our technology along with ST’s technology and products will be a key contributor to VII.”ACS has patent pending technology which addresses a number of VII challenges including providing the statistically determinant channel find necessary for safety systems providing robust communications in a multipath environment and providing precision vehicle location (within 30cm).

Forex Groups - Tips on Trading

Related article:
http://www.newelectronics.co.uk/article/11916/Vehicle-infrastructure-targeted.aspx

comments | Add comment | Report as Spam

STMicroelectronics and US company Automotive Communications Systems are to jointly develop communications ics for vehicle and infrastructure integration (VII) applications. The VII initiative is investigating the potential safety benefits of car to car and car to roadside high go communications. “There is clearly enormous potential for the technology that ACS brings to solving problems facing the VII program,” said Ugo Carena general manager of ST’s automotive products group pictured. “Our capability in automotive wireless communication and location coupled with ACS’ technology ordain provide significant advantages to the government auto companies and their suppliers.”“We are excited to be working with … STMicroelectronics,” said Milt Baker ceo of ACS. “The synergy of our technology along with ST’s technology and products will be a key contributor to VII.”ACS has patent pending technology which addresses a number of VII challenges including providing the statistically determinant channel access necessary for safety systems providing robust communications in a multipath environment and providing precision vehicle location (within 30cm).

Forex Groups - Tips on Trading

Related article:
http://www.newelectronics.co.uk/article/11916/Vehicle-infrastructure-targeted.aspx

comments | Add comment | Report as Spam

STMicroelectronics and US company Automotive Communications Systems are to jointly develop communications ics for vehicle and infrastructure integration (VII) applications. The VII initiative is investigating the potential safety benefits of car to car and car to roadside high speed communications. “There is clearly enormous potential for the technology that ACS brings to solving problems facing the VII program,” said Ugo Carena command manager of ST’s automotive products group pictured. “Our capability in automotive wireless communication and location coupled with ACS’ technology will provide significant advantages to the government auto companies and their suppliers.”“We are excited to be working with … STMicroelectronics,” said Milt Baker ceo of ACS. “The synergy of our technology along with ST’s technology and products will be a key contributor to VII.”ACS has patent pending technology which addresses a number of VII challenges including providing the statistically determinant bring access necessary for safety systems providing robust communications in a multipath environment and providing precision vehicle location (within 30cm).

Forex Groups - Tips on Trading

Related article:
http://www.newelectronics.co.uk/article/11916/Vehicle-infrastructure-targeted.aspx

comments | Add comment | Report as Spam

STMicroelectronics and US affiliate Automotive Communications Systems are to jointly develop communications ics for vehicle and infrastructure integration (VII) applications. The VII initiative is investigating the potential safety benefits of car to car and car to roadside high speed communications. “There is clearly enormous potential for the technology that ACS brings to solving problems facing the VII program,” said Ugo Carena general manager of ST’s automotive products group pictured. “Our capability in automotive wireless communication and location coupled with ACS’ technology will provide significant advantages to the government auto companies and their suppliers.”“We are excited to be working with … STMicroelectronics,” said Milt Baker ceo of ACS. “The synergy of our technology along with ST’s technology and products will be a key contributor to VII.”ACS has procure pending technology which addresses a number of VII challenges including providing the statistically determinant channel access necessary for safety systems providing robust communications in a multipath environment and providing precision vehicle location (within 30cm).

Forex Groups - Tips on Trading

Related article:
http://www.newelectronics.co.uk/article/11916/Vehicle-infrastructure-targeted.aspx

comments | Add comment | Report as Spam

STMicroelectronics and US company Automotive Communications Systems are to jointly develop communications ics for vehicle and infrastructure integration (VII) applications. The VII initiative is investigating the potential safety benefits of car to car and car to roadside high speed communications. “There is clearly enormous potential for the technology that ACS brings to solving problems facing the VII schedule,” said Ugo Carena general manager of ST’s automotive products assort pictured. “Our capability in automotive wireless communication and location coupled with ACS’ technology ordain provide significant advantages to the government auto companies and their suppliers.”“We are excited to be working with … STMicroelectronics,” said Milt Baker ceo of ACS. “The synergy of our technology along with ST’s technology and products will be a key contributor to VII.”ACS has patent pending technology which addresses a number of VII challenges including providing the statistically determinant channel access necessary for safety systems providing robust communications in a multipath environment and providing precision vehicle location (within 30cm).

Forex Groups - Tips on Trading

Related article:
http://www.newelectronics.co.uk/article/11916/Vehicle-infrastructure-targeted.aspx

comments | Add comment | Report as Spam

A new targeted medicate delivery method uses ultrasound to image tumours while also releasing the drug from "nanobubbles" into the tumour. Cancer drugs can be targeted to tumours by delivering them in packets of nanoparticles then releasing them with ultrasound. But this approach can be difficult because it requires a way to image the tumour prior to treatment. Natalya Rapoport. Ph. D.. D. Sc. of the University of Utah in Salt Lake City and colleagues exposit a new method of drug delivery that may address this problem. Their study appears in the July 10 air of the Journal of the National Cancer Institute. Nanobubbles filled with the chemotherapy medicate doxorubicin were injected into mice. The bubbles accumulated in the tumours where they combined to form larger "microbubbles." When exposed to ultrasound the bubbles generated echoes which made it possible to image the tumour. The sound energy from the ultrasound popped the bubbles releasing the drug. In mice treated with this method the nanobubbles were more effective at blocking tumour growth than other nanoparticle delivery methods. "Microbubble formulations have been developed for combining ultrasonic tumour imaging and ultrasound-enhanced chemotherapeutic treatment," the authors write. (Source: Journal of the National Cancer Institute : University of Utah : November 2007) ^ Please be aware that we do not give advice on your individual medical condition. if you want advice gratify see your treating physician. Information on this site must be discussed with your treating doctor. Virtual Medical Centre &write; 2002 - 2008 | Last updated 1 Mar 2008

Forex Groups - Tips on Trading

Related article:
http://www.virtualcancercentre.com/news.asp?artid=10628

comments | Add comment | Report as Spam

A new targeted drug delivery method uses ultrasound to image tumours while also releasing the drug from "nanobubbles" into the tumour. Cancer drugs can be targeted to tumours by delivering them in packets of nanoparticles then releasing them with ultrasound. But this approach can be difficult because it requires a way to image the tumour prior to treatment. Natalya Rapoport. Ph. D.. D. Sc. of the University of Utah in Salt Lake City and colleagues exposit a new method of drug delivery that may address this problem. Their study appears in the July 10 issue of the Journal of the National Cancer Institute. Nanobubbles filled with the chemotherapy drug doxorubicin were injected into mice. The bubbles accumulated in the tumours where they combined to create larger "microbubbles." When exposed to ultrasound the bubbles generated echoes which made it possible to image the tumour. The sound energy from the ultrasound popped the bubbles releasing the drug. In mice treated with this method the nanobubbles were more effective at blocking tumour growth than other nanoparticle delivery methods. "Microbubble formulations have been developed for combining ultrasonic tumour imaging and ultrasound-enhanced chemotherapeutic treatment," the authors write. (Source: Journal of the National Cancer Institute : University of Utah : November 2007) ^ Please be aware that we do not give advice on your individual medical condition. if you want advice please see your treating physician. Information on this site must be discussed with your treating doctor. Virtual Medical Centre © 2002 - 2008 | Last updated 1 Mar 2008

Forex Groups - Tips on Trading

Related article:
http://www.virtualcancercentre.com/news.asp?artid=10628

comments | Add comment | Report as Spam

A new targeted drug delivery method uses ultrasound to image tumours while also releasing the drug from "nanobubbles" into the tumour. Cancer drugs can be targeted to tumours by delivering them in packets of nanoparticles then releasing them with ultrasound. But this come can be difficult because it requires a way to image the tumour prior to treatment. Natalya Rapoport. Ph. D.. D. Sc. of the University of Utah in flavor Lake City and colleagues describe a new method of drug delivery that may communicate this problem. Their study appears in the July 10 issue of the Journal of the National Cancer Institute. Nanobubbles filled with the chemotherapy drug doxorubicin were injected into mice. The bubbles accumulated in the tumours where they combined to create larger "microbubbles." When exposed to ultrasound the bubbles generated echoes which made it possible to image the tumour. The sound energy from the ultrasound popped the bubbles releasing the drug. In mice treated with this method the nanobubbles were more effective at blocking tumour growth than other nanoparticle delivery methods. "Microbubble formulations have been developed for combining ultrasonic tumour imaging and ultrasound-enhanced chemotherapeutic treatment," the authors write. (Source: Journal of the National Cancer Institute : University of Utah : November 2007) ^ Please be aware that we do not give advice on your individual medical condition. if you want advice gratify see your treating physician. Information on this place must be discussed with your treating doctor. Virtual Medical Centre © 2002 - 2008 | Last updated 1 Mar 2008

Forex Groups - Tips on Trading

Related article:
http://www.virtualcancercentre.com/news.asp?artid=10628

comments | Add comment | Report as Spam

A new targeted drug delivery method uses ultrasound to image tumours while also releasing the drug from "nanobubbles" into the tumour. Cancer drugs can be targeted to tumours by delivering them in packets of nanoparticles then releasing them with ultrasound. But this come can be difficult because it requires a way to image the tumour prior to treatment. Natalya Rapoport. Ph. D.. D. Sc. of the University of Utah in Salt Lake City and colleagues describe a new method of drug delivery that may address this problem. Their study appears in the July 10 air of the Journal of the National Cancer Institute. Nanobubbles filled with the chemotherapy drug doxorubicin were injected into mice. The bubbles accumulated in the tumours where they combined to form larger "microbubbles." When exposed to ultrasound the bubbles generated echoes which made it possible to image the tumour. The sound energy from the ultrasound popped the bubbles releasing the drug. In mice treated with this method the nanobubbles were more effective at blocking tumour growth than other nanoparticle delivery methods. "Microbubble formulations undergo been developed for combining ultrasonic tumour imaging and ultrasound-enhanced chemotherapeutic treatment," the authors write. (obtain: Journal of the National Cancer Institute : University of Utah : November 2007) ^ Please be aware that we do not furnish advice on your individual medical instruct. if you want advice please see your treating physician. Information on this site must be discussed with your treating adulterate. Virtual Medical Centre © 2002 - 2008 | measure updated 1 Mar 2008

Forex Groups - Tips on Trading

Related article:
http://www.virtualcancercentre.com/news.asp?artid=10628

comments | Add comment | Report as Spam

A new targeted drug delivery method uses ultrasound to visualise tumours while also releasing the medicate from "nanobubbles" into the tumour. Cancer drugs can be targeted to tumours by delivering them in packets of nanoparticles then releasing them with ultrasound. But this approach can be difficult because it requires a way to image the tumour prior to treatment. Natalya Rapoport. Ph. D.. D. Sc. of the University of Utah in Salt Lake City and colleagues describe a new method of drug delivery that may communicate this problem. Their study appears in the July 10 issue of the Journal of the National Cancer initiate. Nanobubbles filled with the chemotherapy medicate doxorubicin were injected into mice. The bubbles accumulated in the tumours where they combined to form larger "microbubbles." When exposed to ultrasound the bubbles generated echoes which made it possible to image the tumour. The sound energy from the ultrasound popped the bubbles releasing the medicate. In mice treated with this method the nanobubbles were more effective at blocking tumour growth than other nanoparticle delivery methods. "Microbubble formulations have been developed for combining ultrasonic tumour imaging and ultrasound-enhanced chemotherapeutic treatment," the authors create verbally. (Source: Journal of the National Cancer Institute : University of Utah : November 2007) ^ Please be aware that we do not give advice on your individual medical instruct. if you want advice please see your treating physician. Information on this site must be discussed with your treating doctor. Virtual Medical Centre © 2002 - 2008 | Last updated 1 Mar 2008

Forex Groups - Tips on Trading

Related article:
http://www.virtualcancercentre.com/news.asp?artid=10628

comments | Add comment | Report as Spam